Extendicare Valuation
| EXETFDelisted Stock | USD 5.00 0.00 0.00% |
At this time, the firm appears to be overvalued. Extendicare shows a prevailing Real Value of $4.21 per share. The current price of the firm is $5.0. Our model computes the value of Extendicare from reviewing the firm fundamentals such as Shares Outstanding of 83.94 M, current valuation of 556.43 M, and Profit Margin of 0.05 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Extendicare's price fluctuation is very steady at this time. Calculation of the real value of Extendicare is based on 3 months time horizon. Increasing Extendicare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Extendicare pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Extendicare. Since Extendicare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Extendicare Pink Sheet. However, Extendicare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.0 | Real 4.21 | Hype 5.0 | Naive 4.97 |
The real value of Extendicare Pink Sheet, also known as its intrinsic value, is the underlying worth of Extendicare Company, which is reflected in its stock price. It is based on Extendicare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Extendicare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Extendicare helps investors to forecast how Extendicare pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Extendicare more accurately as focusing exclusively on Extendicare's fundamentals will not take into account other important factors: Extendicare Total Value Analysis
Extendicare is currently anticipated to have takeover price of 556.43 M with market capitalization of 419.69 M, debt of 463.27 M, and cash on hands of 174.61 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Extendicare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
556.43 M | 419.69 M | 463.27 M | 174.61 M |
Extendicare Investor Information
About 13.0% of the company shares are held by company insiders. The book value of Extendicare was currently reported as 1.49. The company has Price/Earnings (P/E) ratio of 500.0. Extendicare last dividend was issued on the 30th of January 2023. Based on the measurements of operating efficiency obtained from Extendicare's historical financial statements, Extendicare is not in a good financial situation at the present time. It has a very high likelihood of going through financial trouble in December.Extendicare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Extendicare has an asset utilization ratio of 135.15 percent. This implies that the Company is making $1.35 for each dollar of assets. An increasing asset utilization means that Extendicare is more efficient with each dollar of assets it utilizes for everyday operations.Extendicare Ownership Allocation
Extendicare holds a total of 83.94 Million outstanding shares. Extendicare shows 13.15 percent of its outstanding shares held by insiders and 17.61 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Extendicare Profitability Analysis
The company reported the revenue of 1.22 B. Net Income was 11.5 M with profit before overhead, payroll, taxes, and interest of 283.88 M.Extendicare Past Distributions to stockholders
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Extendicare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Extendicare and how it compares across the competition.
About Extendicare Valuation
The pink sheet valuation mechanism determines Extendicare's current worth on a weekly basis. Our valuation model uses a comparative analysis of Extendicare. We calculate exposure to Extendicare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Extendicare's related companies.Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. Extendicare Inc. was founded in 1968 and is based in Markham, Canada. Extendicare operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Extendicare's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Extendicare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Extendicare's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Extendicare's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Extendicare's revenue streams: Identify Extendicare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Extendicare's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Extendicare's growth potential: Evaluate Extendicare's management, business model, and growth potential.
- Determine Extendicare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Extendicare's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Extendicare represents a small ownership stake in the entity. As a stockholder of Extendicare, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Extendicare Dividends Analysis For Valuation
Please note that Extendicare has scaled down on payment of dividends at this time.
There are various types of dividends Extendicare can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Extendicare shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Extendicare directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Extendicare pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Extendicare by the value of the dividends paid out.
Extendicare Growth Indicators
Investing in growth stocks can be very risky. If the company such as Extendicare does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 89.6 M | |
| Quarterly Earnings Growth Y O Y | 73.236 | |
| Forward Price Earnings | 28.9855 | |
| Retained Earnings | -402.5 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Extendicare Pink Sheet
If you are still planning to invest in Extendicare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Extendicare's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |